1. Home
  2. >>
  3. tiny
  4. >>
  5. Injectsense: A tiny eye implant receives a $ 1.7 million grant

Injectsense: A tiny eye implant receives a $ 1.7 million grant

Injectsense: A tiny eye implant receives a $ 1.7 million grant

Injectsense, a startup founded in 2014 by Ariel Cao, has developed an eye implant smaller than a grain of rice. It is about a device that can measure the pressure inside the eyeball, but not once. Once the device has been implanted in the back of the eye, it will remain there for up to 80 years, continuously transmitting data.

The implantation of the Injectsense device will be very simple

There intraocular pressure is a significant risk factor for glaucoma, a disease that causes damage to the optic nerve and leads to blindness. One of the ways to identify the onset of the disease is the measurement of pressure, an analysis is not particularly pleasant, which involves the administration of a few paralyzing drops and the touch on the eye with a device called a tonometer by the ophthalmologist.

  Tiny bursts of gas to create dynamic Braille displays

This type of analysis would no longer be needed once implanted the Injectsense device. Inserting the device into the eye requires a short, non-surgical procedure, an intravitreal injection in the back of the eye. During the injection there is only a slight pressure, but no pain. And once implanted, there will be no need to go back to the doctor to check the intraocular pressure, the Injectsense implant is designed to continuously transmit data wirelessly.

To recharge the device just wear a pair of special glasses for 5 minutes each week. This very special pair of matching glasses also allows the device to download all recorded intraocular pressure data to a cloud, so our ophthalmologist can easily access and examine them. According to Cao, the device’s battery can continue in this pattern for 80 years.

  No Man’s Sky players are filling planets with tiny houses

A large grant to continue with the experimentation

Based on the studies carried out to date, both on animals and in vitro, in March Injectsense received a two-year research grant for innovation research for small businesses (SBIR) from $ 1.7 million from the National Eye Institute. This was possible thanks to a revolutionary device designation by the U.S. Food and Drug Administration obtained in 2020.

So far the Injectsense device has been tested on rabbits only and in the tests conducted so far the devices seem to have worked well. There were no eye problems in the animals and the devices were successfully implanted. But the data has not yet been peer-reviewed.

  Tiny Tina’s Wonderlands will have procedural loot gear with perks

This new grant will therefore pave the way for further animal and laboratory testing at the Johns Hopkins Wilmer Eye Institute. It is also planned for this year the launch of a pilot study in humans in Chile.

The importance of glaucoma prevention and treatment

Glaucoma is the second leading cause of blindness in the world and the leading cause of blindness in the United States, affecting approximately 3 million people. Worldwide, cases of glaucoma are projected to increase from 57.5 million to over 111.8 million by 2040. For this reason, it can be critically important to recognize the disease in time.

  Tiny Tina’s Wonderlands will have a gameplay “soon”

To combat glaucoma, measuring blood pressure is helpful. Numerous scientific studies have indeed shown that intraocular pressure is a major risk factor for glaucoma. It’s not the only risk factor, and not all people with glaucoma have elevated intraocular pressure, but it’s still considered the most important.

But simply measuring intraocular pressure with the tools that ophthalmologists already have at their disposal leads to individual measurements during follow-up visits. This is not relevantand key pressure fluctuations which scientists know occur inside the eye. Also, while it is possible, though certainly not practical, to measure intraocular pressure regularly during the day, measuring these changes at night is difficult. And the data suggested it is right at night that the greatest fluctuations in intraocular pressure occur, possibly reaching a peak.

  DelFly: the tiny robot with wings that will change the future of airplanes

For example, intraocular pressure measurements were taken in 24 patients with early stage glaucoma during a study. every two hours. The authors of this study suggested that intraocular pressure measurement only at the examination “probably is not adequate for optimal management of glaucoma”.

Injectsense could allow continuous monitoring of intraocular pressure

Precisely for this reason, an ocular implant like the one designed by Injectsense could mark a turning point in this sense. Our ophthalmologist would have it available the complete set of data and fluctuations in intraocular pressureallowing for better management of the disease or even the possibility of early diagnosis.

  Velocity 2X’s FuturLab takes on PlayStation VR with Tiny Trax

The device currently already exists, but there is still a lot of work to be done. Injectsense is in fact still in the testing phase on animals and its researchers still have a long way to go before they are ready for FDA review.

Ph. Credit: Injectsense